| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13107-108-20 | 13107-108 | HUMAN PRESCRIPTION DRUG | HYDROMORPHONE HYDROCHLORIDE | HYDROMORPHONE HYDROCHLORIDE | TABLET | ORAL | 20160517 | N/A | ANDA | ANDA205814 | Aurolife Pharma, LLC | HYDROMORPHONE HYDROCHLORIDE | 4 mg/1 | 20 TABLET in 1 BOTTLE (13107-108-20) |
| 13107-108-99 | 13107-108 | HUMAN PRESCRIPTION DRUG | HYDROMORPHONE HYDROCHLORIDE | HYDROMORPHONE HYDROCHLORIDE | TABLET | ORAL | 20160517 | N/A | ANDA | ANDA205814 | Aurolife Pharma, LLC | HYDROMORPHONE HYDROCHLORIDE | 4 mg/1 | 1000 TABLET in 1 BOTTLE (13107-108-99) |